Supplemental Digital Content is available in the text
Keywords: acupuncture, knee osteoarthritis, meta-analysis, moxibustion, pain relief, quality of life, systematic review
Abstract
Objective:
The aim of this systematic review and meta-analysis is to assess the efficacy of acupuncture and moxibustion in pain relief and quality of life improvement of knee osteoarthritis (KOA) patients.
Methods:
The following databases will be searched: MEDLINE, EMBASE, the Cochrane Library, Web of Science, Chinese Biomedical Literature Database, Chinese Nation Knowledge Infrastructure, Wanfang Database, the Chongqing VIP from inception to May 1, 2020. All randomized controlled trials (RCTs) used acupuncture or moxibustion to relieve pain and improve quality of life (QoL) among KOA patients will be included. Study selection, data extraction, quality assessment and assessment of risk bias will be performed by 2 reviewers independently. Data synthesis will be performed using Review Manager V5.3 software. A meta-analysis will be performed when there is sufficient available data.
PROSPERO registration number:
CRD42020169724
1. Introduction
Knee osteoarthritis (KOA) is a common form of osteoarthritis, often caused by focal loss of articular cartilage, marginal, and central new bone formation.[1,2] Most patients with KOA are associated with pain, swelling, dysfunction, and deformity in knee joint clinically.[2] The global age-standardized prevalence of KOA is 3.8%,[3] affecting more than 9 million individuals in the United States.[4] Pain is the main symptom of KOA and is the first reason for patients to go to their doctors, which affects the quality of life of patients seriously and might induce physical disability of knee furtherly.[1,5]
The main interventions to treat KOA including patient education, non-pharmacological therapy, pharmacological therapy, and surgery.[1,6–8] The widely-used pharmacological treatments, non-steroidal anti-inflammatory drugs (NSAIDs), are unsatisfactory with their significant side effects.[9] Although knee replacement is effective and successful in most cases,[10] 20% of patients remain unsatisfied at 1 year after a technically successful procedure.[11]
Hence, non-pharmacological approaches are more and more popular to be used to manage chronic knee pain typically due to knee osteoarthritis.[12,13] Acupuncture and moxibustion, the most common complementary and alternative therapy, have significant effects on KOA, including pain relief,[14,15] periarticular swelling reduction,[16] knee function,[15] and quality of life (QoL) improvement.[17] However, the efficacy of acupuncture and moxibustion exist inconsistency. A study published in JAMA in 2014 has reported that acupuncture conferred no benefit over sham for pain or knee function.[18] Several reviews of acupuncture and moxibustion for chronic knee pain have been published from 2007 to 2017.[19,20] The systematic review in 2017 concluded that acupuncture may be effective for chronic knee pain, but it was unable to draw any strong conclusions because of heterogeneity and methodological limitations.[20]
In this study, we will perform a systematic review and meta-analysis of double-blind, randomized, controlled studies of acupuncture, and moxibustion that presented data on pain relief and quality of life improvement among knee osteoarthritis. We will compare the differences in pain relief and quality of life improvement in KOA patients who received acupuncture and/or moxibustion treatments with those received sham acupuncture or moxibustion, placebo control, or other active therapies.
2. Methods and design
2.1. Inclusion criteria
2.1.1. Type of studies
Randomized controlled trials (RCT) reported in English or Chinese will be included. Other study design will be excluded. There will be no restriction on publication date.
2.1.2. Type of participants
Studies enrolling adult patients (aged ≥ 38 years) diagnosed as knee osteoarthritis will be included. There will be no restrictions on age, gender, race, or nation.
2.1.3. Type of interventions
The acupuncture and moxibustion of the experimental group must include forms of needle insertion including fire needle, floating needle, electroacupuncture, etc. or moxibustion at acupoints or trigger points. Besides, acupuncture and moxibustion plus other interventions will also be included. There will be no restrictions on the retaining time, frequency, sessions of acupuncture, and moxibustion.
2.1.4. Type of comparators
The control group with sham acupuncture or moxibustion, placebo control, or other active therapies will be included. There will be no restrictions on the retaining time, frequency, sessions of comparators.
2.1.5. Outcome measurements
Primary outcomes will include the changes in the Visual Analogue Scale (VAS) scores, the McGill Pain Questionnaire (MPQ) scores and the changes in the Short Form health survey (SF-36) scores from baseline to the available follow-up. Secondary outcomes will contain the changes in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the incidence rate of adverse events from baseline to the available follow-up.
2.2. Exclusion criteria
Non-RCTs, quasi-RCTs, crossover trials, case report, animal studies, experts experience, conference articles will be excluded. Studies comparing the effect of different acupuncture or moxibustion therapies will be excluded. Studies comparing the effect of acupuncture and moxibustion will also be excluded. Studies with a sample size of less than 10 subjects in each group will be excluded.
2.3. Search strategy
2.3.1. Electronic searches
From the inception to May 1, 2020, the following databases will be searched: MEDLINE, EMBASE, the Cochrane Library, Web of Science, Chinese Biomedical Medical Database, Chinese Nation Knowledge Infrastructure, Wanfang Database, the Chongqing VIP. The searching strategy of MEDLINE is presented in Supplemental Digital Content (Appendix 1, http://links.lww.com/MD/E229). This search strategy will be modified to be suitable for other electronic databases.
2.3.2. Searching other resources
Unpublished or ongoing trial data will also be searched from the following clinical trial registries: The National Institutes of Health clinical registry Clinical Trials, the Chinese clinical registry, the Australian New Zealand Clinical Trials Registry, the International Clinical Trials Registry Platform. Ambiguous literatures and reference lists of identified publications will be checked manually.
2.4. Data collection
2.4.1. Studies selection
All the studies of electronic searches and other sources will be imported to Endnote version X9 software, and the duplicated studies will be filtered. The titles and abstracts of potentially qualified studies will be screened by two reviewers (SC and JZ) independently. And the studies not meeting the inclusion criteria will be excluded. The full text will be further screened if the studies cannot be estimated according to the titles and abstracts. After screening, two reviewers will cross-check the included studies. The inconsistent opinions between the two reviewers will be resolved through discussion or a third reviewer (GX). Details of the selection procedure for studies are shown in a Preferred Reporting Item for Systematic review and Meta-analysis protocol (PRISMA-P) flow chart (Fig. 1).
Figure 1.

Flow diagram of study selection process.
2.4.2. Data extraction
The following information from the included studies will be extracted by two reviewers (SC and MX) using a standard form: the first author, year of publication, country, funding supports, the mean age of participants, sex, ethnicity, education, illness duration, study design, sample size, diagnostic criteria, method of randomization, blinding, interventions and controls, method of analysis, outcome measures, mean and SD of outcomes, adverse events. The disagreement between the two reviewers will be solved by discussion or a third reviewer (GX). The extraction data will be listed in Microsoft Excel, and JZ will check the entered data to ensure the consistency and correct data entry errors.
2.5. Risk of bias assessment
The risk of bias of the included trials will be evaluated by two reviewers (SC and GX) independently using the Cochrane risk of bias tool (http://www.cochrane-handbook.org). The following 6 items will be assessed, including: random sequence generation, allocation concealment, blind subjects and therapists, blind assessors, incomplete outcome data, selective reporting, and other bias when required.[21] The risk of bias in each item is rated as “high”, “low risk”, or “unclear of bias”. The disagreements will be resolved through discussion or the third reviewer (MX).
2.6. Dealing with missing data
If the data of the primary studies is missing, the authors will be contact for the information. If the missing data cannot be obtained, the studies will only be included for narrative analysis.
2.7. Quality of evidence assessment
The quality of evidence of outcomes will be assessed by two reviewers independently according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. The GRADE system includes 5 items: the risk of bias, inconsistency, indirectness, imprecision, and publication bias.[22,23] The quality of evidence will be rated as “high”, “moderate”, “low” or “very low”.
2.8. Data analysis
2.8.1. Data synthesis
To summarize the effects of acupuncture and moxibustion on outcomes, the weighted mean differences (WMD) with 95% confidence interval (CI) from each study will be synthesized using Review Manager version 5.3 (RevMan V5.3, the Nordic Cochrane Centre, Copenhagen, Denmark). The relative risk (RR) with 95% CI will also be calculated. The variance of the change will be imputed using a correlation factor of 0.4 as suggested by the Cochrane Collaboration. If excessive statistical heterogeneity is not existing, we will pool data across studies using fixed-effects model for meta-analysis. When statistical heterogeneity exists, a random-effects model will be used for meta-analysis. Besides, a narrative and qualitative summary will also be provided.
2.8.2. Assessment of heterogeneity
The heterogeneity will be analyzed through Chi-Squared (X2) test by using RevMan V5.3 according to the Cochrane Handbook. P value of less than 0.10 will be considered significant. Moreover, we will calculate the I2 value on the meta-analysis to quantify the impact of the statistical heterogeneity. If the I2 value is over than 40%, the potential cause of the significant heterogeneity will be further explored using meta-regression analysis.
2.8.3. Subgroup analysis
If the number of included studies is enough, subgroup analysis will be conducted according to the different types of acupuncture and moxibustion, age, sex, control interventions, treatment frequency.
2.8.4. Sensitivity analysis
In order to verify the stability of the primary outcomes, sensitivity analysis will be performed according to the sample size, study design, methodological quality, the effect of missing data of the included studies.
2.8.5. Assessment of publication biases
Funnel plots will be performed to assess the reporting bias when more than 10 trials are included. If the funnel plots are asymmetric, we will try to interpret the funnel plots asymmetry.
3. Discussion
KOA is a common chronic degenerative disease of knee joint in elderly,[24] which is significantly impairs the physical function and QoL of target population.[25,26] Current regimes are aiming to reliving symptom and recovering physical function because KOA cannot be cured.[10,27] Previous reviews have been performed to compare the effectiveness and safety between moxibustion and sham control and conducted that moxibustion treatment is equal to the oral drugs and intra-articular injections in treating patients with KOA.[28,29] Another updated systematic review has assessed the effectiveness and safety of acupuncture for the treatment of chronic knee pain.[20] Chronic knee pain can be induced due to knee osteoarthritis, rheumatoid arthritis, urarthritis, meniscus injury, etc., which may bring about the heterogeneity limitations of the included trials in the above review.[20]
Hence, this study aims to investigate effectiveness of acupuncture and moxibustion for relieving pain and improving the QoL of the patients with KOA. The results of this SR will provide more reliable evidence of acupuncture and moxibustion for relieving pain and improving the QoL, in order to better understand the potential benefits of acupuncture and moxibustion and broaden the clinical application. The results of this review will be reported according to the Consolidation of Standard for Reporting Trials guidelines (CONSORT)[30] and recommendations described in PRISMA statement and the Cochrane Handbook for Intervention Reviews.
There are some limitations in this review. Different types of acupuncture and moxibustion may cause considerable heterogeneity in this systematic review. So subgroup analysis will be performed based on the type of acupuncture and moxibustion if possible. Because of the barrier of language, only trials published in English or Chinese will be included.
Author contributions
Conceptualization: S Cheng, M Liu.
Data curation: S Cheng, J Zhou, G Xu, M Liu.
Methodology: S Cheng, J Zhou, G Xu, M Xin, M Liu.
Project administration: G Xu, Y Cheng.
Writing – original draft: S Cheng, J Zhou, G Xu.
Writing – review & editing: M Xin, Y Qu, Y Zhou, Mi Liu, X Chang, M Liu.
Supplementary Material
Footnotes
Abbreviations: CI = confidence interval, CONSORT = consolidation of standard for reporting trials guidelines, GRADE = grading of recommendations assessment = development and evaluation, KOA = knee osteoarthritis, MPQ = McGill pain questionnaire, NSAIDs = non-steroidal anti-inflammatory drugs, PRISMA = the preferred reporting item for systematic review and meta-analysis, QoL = quality of life, RCT = randomized controlled trials, RR = relative risk, SF-36 = short-form health survey, VAS = visual analogue scale, WMD = weighted mean differences, WOMAC = Western Ontario and McMaster Universities osteoarthritis index.
How to cite this article: Cheng S, Zhou J, Xu G, Xin M, Cheng Y, Qu Y, Zhou Y, Liu M, Chang X, Liu M. Acupuncture and moxibustion for pain relief and quality of life improvement in patients with knee osteoarthritis: a protocol for systematic review and meta-analysis. Medicine. 2020;99:22(e20171).
SC, JZ, and GX contributed equally to this article.
This paper is funded by grants from the National Basic Research Program of China (973 Program, 2015CB554502), the Training Program for Excellent Young Innovators of Changsha (201961), and the Open Fund Project of First-rate Discipline of Traditional Chinese Medicine (2018ZYX04). Provider just financially supports this study, but does not involve all sections of this study, and does not have conflicts interest related to this study.
This review does not require ethical approval. The results of this review may be published in a peer-reviewed journal or disseminated at relevant conferences.
The authors have no conflicts of interest to disclose.
All data generated or analyzed during this study are included in this published article [and its supplementary information files].
Supplemental Digital Content is available for this article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.md-journal.com).
References
- [1].Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Zhang W, Doherty M, Peat G, et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis 2010;69:483–9. [DOI] [PubMed] [Google Scholar]
- [3].Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014;73:1323–30. [DOI] [PubMed] [Google Scholar]
- [4].Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Woolf AD, Akesson K. Understanding the burden of musculoskeletal conditions. The burden is huge and not reflected in national health priorities. BMJ (Clinical research ed) 2001;322:1079–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Guidelines ACoRSoO. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905–15. [DOI] [PubMed] [Google Scholar]
- [7].Yurtkuran M, Kocagil T, TENS. electroacupuncture and ice massage: comparison of treatment for osteoarthritis of the knee. Am J Acupunct 1999;27:133–40. [PubMed] [Google Scholar]
- [8].Dieppe P, Basler HD, Chard J, et al. Knee replacement surgery for osteoarthritis: effectiveness, practice variations, indications and possible determinants of utilization. Rheumatology (Oxford, England) 1999;38:73–83. [DOI] [PubMed] [Google Scholar]
- [9].Manyanga T, Froese M, Zarychanski R, et al. Pain management with acupuncture in osteoarthritis: a systematic review and meta-analysis. BMC Complement Altern Med 2014;14:312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137–62. [DOI] [PubMed] [Google Scholar]
- [11].Baker PN, van der Meulen JH, Lewsey J, et al. The role of pain and function in determining patient satisfaction after total knee replacement. Data from the National Joint Registry for England and Wales. J Bone Joint Surg Br 2007;89:893–900. [DOI] [PubMed] [Google Scholar]
- [12].Fernandes L, Hagen KB, Bijlsma JW, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 2013;72:1125–35. [DOI] [PubMed] [Google Scholar]
- [13].Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012;64:465–74. [DOI] [PubMed] [Google Scholar]
- [14].Helianthi DR, Simadibrata C, Srilestari A, et al. Pain reduction after laser acupuncture treatment in geriatric patients with knee osteoarthritis: a randomized controlled trial. Acta Med Indones 2016;48:114–21. [PubMed] [Google Scholar]
- [15].Ding Y, Wang Y, Shi X, et al. Effect of ultrasound-guided acupotomy vs electro-acupuncture on knee osteoarthritis: a randomized controlled study. J Tradit Chin Med 2016;36:450–5. [PubMed] [Google Scholar]
- [16].Yurtkuran M, Alp A, Konur S, et al. Laser acupuncture in knee osteoarthritis: a double-blind, randomized controlled study. Photomed Laser Surg 2007;25:14–20. [DOI] [PubMed] [Google Scholar]
- [17].Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476–99. [DOI] [PubMed] [Google Scholar]
- [18].Hinman RS, McCrory P, Pirotta M, et al. Acupuncture for chronic knee pain: a randomized clinical trial. JAMA 2014;312:1313–22. [DOI] [PubMed] [Google Scholar]
- [19].White A, Foster NE, Cummings M, et al. Acupuncture treatment for chronic knee pain: a systematic review. Rheumatology (Oxford, England) 2007;46:384–90. [DOI] [PubMed] [Google Scholar]
- [20].Zhang Q, Yue J, Golianu B, et al. Updated systematic review and meta-analysis of acupuncture for chronic knee pain. Acupunct Med 2017;35:392–403. [DOI] [PubMed] [Google Scholar]
- [21].Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed) 2011;343:d5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed) 2008;336:924–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Guyatt GH, Oxman AD, Schunemann HJ, et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011;64:380–2. [DOI] [PubMed] [Google Scholar]
- [24].Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000;133:635–46. [DOI] [PubMed] [Google Scholar]
- [25].Dawson J, Linsell L, Zondervan K, et al. Impact of persistent hip or knee pain on overall health status in elderly people: a longitudinal population study. Arth Rheumat 2005;53:368–74. [DOI] [PubMed] [Google Scholar]
- [26].Palmer KT, Reading I, Calnan M, et al. Does knee pain in the community behave like a regional pain syndrome? Prospective cohort study of incidence and persistence. Ann Rheum Dis 2007;66:1190–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Ren X, Yao C, Wu F, et al. Effectiveness of moxibustion treatment in quality of life in patients with knee osteoarthritis: a randomized, double-blinded, placebo-controlled trial. Evid-Based Complement Altern Med 2015;2015:569523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Song GM, Tian X, Jin YH, et al. Moxibustion is an alternative in treating knee osteoarthritis: the evidence from systematic review and meta-analysis. Medicine 2016;95:e2790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Wang Y, Xie X, Zhu X, et al. Fire-needle moxibustion for the treatment of knee osteoarthritis: a meta-analysis. Evid-Based Complement Alternat Med 2016;2016:1392627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Bian ZX, Shang HC. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2011;154:290–1. author reply 291-292. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
